151. Translational barrier in central region of encephalomyocarditis virus genome. Modulation by elongation factor 2 (eEF-2).
- Author
-
Svitkin YV and Agol VI
- Subjects
- Cell-Free System, Encephalomyocarditis virus metabolism, Genes, Viral, Peptide Elongation Factor 2, Peptide Elongation Factors isolation & purification, Peptides isolation & purification, RNA, Viral isolation & purification, Viral Proteins biosynthesis, Encephalomyocarditis virus genetics, Peptide Elongation Factors physiology, Protein Biosynthesis
- Abstract
A fractionated cell-free system from Krebs-2 cells was prepared which contained ribosomes and a high-speed supernatant. When this system was programmed with encephalomyocarditis virus RNA, the synthesis of a precursor of capsid proteins, polypeptide preA, proceeded at a rate not very different from that observed in unfractionated extracts, whereas the synthesis of more distally encoded proteins, in particular polypeptide F, was greatly retarded, if not abolished. A protein was purified from the cytoplasmic extracts of Krebs-2 cells which greatly enhanced production of polypeptide F as well as other noncapsid proteins in the fractionated system. By several criteria, this protein was identified as eukaryotic elongation factor 2 (eEF-2). By using the ADP-ribosylation assay, it was found that the fractionated system contained about 15% of the amount of eEF-2 present in the unfractionated extracts. The results suggest that changes in the eEF-2 content may affect the elongation rate differently at different regions of the RNA template.
- Published
- 1983
- Full Text
- View/download PDF